Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Vivoryon Therapeutics N.V.. We currently have 12 research reports from 2 professional analysts.
Date | Source | Announcement |
---|---|---|
09Jul19 12:51 | EQS | Vivoryon Therapeutics (PBD-NA): Agreement with MOR in I-O, earlier than expected |
15Jun19 13:34 | EQS | Vivoryon Therapeutics (PBD-NA): Fresh funding for AD. Immuno-oncology optionality explored |
20Mar19 12:33 | EQS | Probiodrug (PBD-NA): $15m cash injection from NIH for US Phase IIb in early Alzheimer's |
01Nov18 09:42 | EQS | Edison Investment Research Limited: Edison issues outlook on Probiodrug (PBD) |
15Oct18 12:47 | EQS | Probiodrug AG: Loss announcement a non-event |
03Sep18 10:24 | EQS | Probiodrug (PBD-NA): Phase IIb trial prep for PQ912 in AD continues: |
13Jul18 10:27 | EQS | Probiodrug (PBD-NA): Positive read-across from BAN2401 Phase II data |
Share: